PDS Biotechnology(PDSB) - 2025 Q4 - Earnings Call Transcript
2026-03-30 13:00
PDS Biotechnology (NasdaqCM:PDSB) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Speaker6Greetings, and welcome to the PDS Biotechnology fourth quarter 2025 earnings call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to ...
SEB (OTCPK:SVKE.F) Update / briefing Transcript
2026-03-30 13:02
SEB (OTCPK:SVKE.F) Update / briefing March 30, 2026 08:00 AM ET Company ParticipantsPawel Wyszynski - Head of Investor RelationsConference Call ParticipantsNone - AnalystNone - AnalystNone - AnalystNone - AnalystNone - AnalystNone - AnalystPawel WyszynskiOkay, I believe we've reached some kind of critical mass, so I'll kick off. Welcome to SEB's Q1 2026 pre-close call. My name is Pawel Wyszynski, and I work in the Investor Relations team here at SEB. This call is being recorded. The script used will be publ ...
Neumora Therapeutics(NMRA) - 2025 Q4 - Earnings Call Transcript
2026-03-30 13:00
Neumora Therapeutics (NasdaqGS:NMRA) Q4 2025 Earnings call March 30, 2026 08:00 AM ET Speaker9Ladies and gentlemen, thank you for standing by. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question and answer session. Please be advised that today's conference is being recorded. I would now like to turn the call over to Helen Rubenstein, Vice President of Investor Relations and Corporate Strategy at Neumora. Please go ahead.Speaker4Good afternoon, a ...
Sigma Lithium(SGML) - 2025 Q4 - Earnings Call Transcript
2026-03-30 12:32
Sigma Lithium (NasdaqCM:SGML) Q4 2025 Earnings call March 30, 2026 07:30 AM ET Company ParticipantsAna Cabral - Co-Chair and CEOAnna Hartley - VP of Investor RelationsModeratorGood morning, ladies and gentlemen. Welcome to Sigma Lithium's 2025 fourth-quarter earnings conference call. We would like to inform you that this event is being recorded, and all participants will be in a listen-only mode during the company's presentation. There will be a replay for this call on the company's website. After the prepa ...
Sigma Lithium(SGML) - 2025 Q4 - Earnings Call Transcript
2026-03-30 12:32
Sigma Lithium (NasdaqCM:SGML) Q4 2025 Earnings call March 30, 2026 07:30 AM ET Company ParticipantsAna Cabral - Co-Chair and CEOAnna Hartley - VP of Investor RelationsModeratorGood morning, ladies and gentlemen. Welcome to Sigma Lithium's 2025 fourth quarter earnings conference call. We would like to inform you that this event is being recorded and all participants will be in a listen-only mode during the company's presentation. There will be a replay for this call on the company's website. After the prepar ...
Sigma Lithium(SGML) - 2025 Q4 - Earnings Call Transcript
2026-03-30 12:30
Sigma Lithium (NasdaqCM:SGML) Q4 2025 Earnings call March 30, 2026 07:30 AM ET Speaker2Good morning, ladies and gentlemen. Welcome to Sigma Lithium's 2025 fourth quarter earnings conference call. We would like to inform you that this event is being recorded and all participants will be in a listen-only mode during the company's presentation. There will be a replay for this call on the company's website. After the prepared remarks, there will be a question and answer session for all participants. At that tim ...
Bicara Therapeutics Inc.(BCAX) - 2025 Q4 - Earnings Call Presentation
2026-03-30 12:30
Q4 / FY 2025 Earnings Call March 30, 2026 © 2024 – 2026 Bicara Therapeutics Forward-looking statements This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding our strategy, business plans and focus; express or implied statements regarding the clinical development of ficerafusp alfa, including anticipated substantial enrollm ...
PAVmed(PAVM) - 2025 Q4 - Earnings Call Presentation
2026-03-30 12:30
LISHAN AKLOG, MD Chairman & CEO DENNIS MCGRATH President & CFO Disclaimer Q4 2025 Business Update March 30, 2026 Nasdaq: PAVM 2 ▪ This presentation may contain certain forward-looking statements related to PAVmed Inc. or Lucid Diagnostics Inc. (the "Companies") that involve risks and uncertainties. ▪ Actual results and events may differ significantly from results and events discussed in forward- looking statements. ▪ Factors that might cause or contribute to such differences include, but are not limited to, ...
Sysco (NYSE:SYY) Earnings Call Presentation
2026-03-30 12:00
March 30, 2026 Sysco to Acquire Restaurant Depot to Expand into High- Margin, Growing and Resilient Cash & Carry Channel FORWARD-LOOKING STATEMENTS This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "expects," "believes," "anticipates," "forecasts," "intends," "seeks," "aims," "plans," ...
Sigma Lithium(SGML) - 2025 Q4 - Earnings Call Presentation
2026-03-30 11:30
Disclaimer No Offer or Solicitation Regarding Securities Fourth Quarter 2025 Earnings Release Presentation 30th of March 2026 : SGML : SGML : S2GM34 This presentation has been prepared by Sigma Lithium Corporation ("Sigma") for general information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of Sigma or its affiliates in any jurisdiction, including but not limited to Canada and the United States. The contents of this presentation should not be in ...